Home
About
Publications Trends
Recent Publications
Expert Search
Archive
post marketing surveillance
How is Post Marketing Surveillance Conducted?
PMS involves several methods such as passive and active surveillance. In
passive surveillance
, healthcare providers and patients report adverse events to national databases like the
Vaccine Adverse Event Reporting System (VAERS)
in the United States.
Active surveillance
actively seeks out information through systems like the
Vaccine Safety Datalink (VSD)
, which uses large linked databases to monitor and evaluate the safety of vaccines.
Frequently asked queries:
What is Post Marketing Surveillance?
How is Post Marketing Surveillance Conducted?
What Are the Challenges in Post Marketing Surveillance?
How Can the Public Contribute to Post Marketing Surveillance?
What are the Future Directions for Post Marketing Surveillance?
What are the Mechanisms Behind Vaccine-Induced Cytokine Storms?
What Role do Vaccines Play in Reducing the Need for Antiviral Therapy?
Why is Vaccine Stability Important?
Why are Booster Shots Necessary?
What are Inactivated Vaccines?
How Does WHO Support Vaccine Accessibility?
What is Vaccine Dosage?
How Can the Public Support Malaria Vaccination Efforts?
What is a Fractional Dose?
Why are Vaccine Reporting Systems Important?
What is Case Detection Rate?
What is Hepatitis C?
How Do Cytotoxic T Cells Respond to Vaccines?
Why Are Some Vaccines Given in Multiple Doses?
What are the Challenges in Developing CSP-based Vaccines?
Follow Us
Facebook
Linkedin
Youtube
Instagram
Top Searches
Cardiovascular Disease
Cholera Vaccination
Hepatitis B
Liver Diseases
Malaria Vaccine
Measles Surveillance
Measles Vaccination
Poliovirus
RNA vaccines
Vaccine Development
Vaccine Exemptions
Vaccine Storage
Partnered Content Networks
Relevant Topics
ACIP guidelines
AllopathicVaccines
Antiviral Therapy
Cardiovascular Disease
chemoprevention
childhood vaccines
Cholera
Chronic Conditions
Cirrhosis
COFs
covid 19 vaccine
COVID-19
COVID-19 vaccines
Cytokine Storm
cytomegalovirus
Diabetes
Drug delivery
exosome
genetic engineering
genomesequencing
Genomic
Geographic Information Systems (GIS) in surveillance
Global Health
Glycemic Control
HBsAg
HBV DNA
HBV vaccination
HCV vaccine development
health systems
Healthcare Management
Hepatitis B (HBV)
Hepatitis B Virus
Hepatitis C (HCV)
Hepatocellular carcinoma (HCC)
Herd immunity
Historical Measles Outbreaks
hydrophobic
Hygiene
Hyperglycemia
immune responses
Immunization
Immunization guidelines
immunizations
immunogenicity
Immunoprophylaxis
latency
Legal implications
lipid
Liver diseases
malaria prevention
Malaria vaccine development
Maternal Health
Measles and Rubella Initiative
Measles control strategies
Measles outbreaks
Measles surveillance
measles vaccination
Measles Vaccination Efficacy
Measles Vaccine Effectiveness
Measles Vaccine Review
Molecular diagnostics
monoclonal antibodies
Mother-to-Child Transmission
mRNA
mRNA vaccines
Multi-Dose
nanocarriers
nanoparticles
nanovaccine
Newborn vaccination
Oral Cholera Vaccine
Paralysis
Pertussis outbreaks
Philosophical exemptions
phylodynamics
physicals
polio vaccine
poliovirus
Polymerase Chain Reaction (PCR)
Preventive Measures
Public Health
Public health campaigns
Public health ethics
Recent Measles Outbreaks
Religious exemptions
RNA
RNA vaccines
RTS
S/AS01
SARS-CoV2
Single-Dose
Supplementary immunization activities (SIAs)
systems biology
Telemedicine
transcriptional profiling
vaccination
Vaccination programs
Vaccine
Vaccine coverage
vaccine derivative poliovirus
vaccine derived poliovirus
vaccine development
vaccine efficacy
Vaccine exemptions
Vaccine hesitancy
Vaccine Storage
Vaccine Transport
vaccine transportation
Vaccine-preventable diseases
VDPVs
WHO measles initiatives
Subscribe to our Newsletter
Stay updated with our latest news and offers related to Vaccine.
Subscribe